Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

WM S1

Next Previous
Drug Profile

WM S1

Alternative Names: 1030; KDDF-201612-12; WM-S1-001

Latest Information Update: 28 Feb 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioGenetics; Well Marker Bio
  • Developer KyungNam BioPharma; Wellmarker Bio
  • Class Antineoplastics; Small molecules
  • Mechanism of Action Receptor protein-tyrosine kinase antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I Cholangiocarcinoma; Colorectal cancer; Head and neck cancer; Non-small cell lung cancer; Pancreatic cancer

Most Recent Events

  • 28 Feb 2025 No recent reports of development identified for phase-I development in Colorectal-cancer in Australia (PO)
  • 01 Dec 2022 Phase-I clinical trials in Cholangiocarcinoma in Australia (PO) (Well Marker Bio pipeline, December 2022)
  • 01 Dec 2022 Phase-I clinical trials in Head and neck cancer in Australia (PO) (Well Marker Bio pipeline, December 2022)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top